Potrójnie ujemny rak piersi: badanie fazy II/III leku capecitabine i paclitaxel
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast…